COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy

Allergy. 2022 Mar;77(3):1048-1051. doi: 10.1111/all.15178. Epub 2021 Nov 25.

Authors

Aleena Banerji¹, Anna R Wolfson¹, Lacey B Robinson¹, Aubree E McMahon¹, Amelia S Cogan¹, Rebecca R Saff¹, Kimberly G Blumenthal^{1

2}

Affiliations

¹ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, Massachusetts, USA.

No abstract available

Keywords: COVID; PEG; SARS-CoV; docetaxel; drug allergy; paclitaxel; vaccine allergy.

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19* / prevention & control
Docetaxel / adverse effects
Humans
Hypersensitivity*
Paclitaxel / adverse effects
SARS-CoV-2

Substances

COVID-19 Vaccines
Docetaxel
Paclitaxel